[
  {
    "ts": null,
    "headline": "Why Investors View Bristol‑Myers Squibb (BMY) as a Safe Dividend Stock for Income",
    "summary": "Bristol-Myers Squibb Company (NYSE:BMY) is included among the 10 Best and Safe Dividend Stocks to Buy Now. Bristol-Myers Squibb Company (NYSE:BMY) presents a strong case for investors looking for both value and reliable income. While the company has faced challenges in the past, it has recently gained approval for several important new drugs, strengthening its […]",
    "url": "https://finnhub.io/api/news?id=3c8349128e1247262cec156b5baf42893ea9cb7980811f364e40899f400c5be8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753809940,
      "headline": "Why Investors View Bristol‑Myers Squibb (BMY) as a Safe Dividend Stock for Income",
      "id": 136130153,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Bristol-Myers Squibb Company (NYSE:BMY) is included among the 10 Best and Safe Dividend Stocks to Buy Now. Bristol-Myers Squibb Company (NYSE:BMY) presents a strong case for investors looking for both value and reliable income. While the company has faced challenges in the past, it has recently gained approval for several important new drugs, strengthening its […]",
      "url": "https://finnhub.io/api/news?id=3c8349128e1247262cec156b5baf42893ea9cb7980811f364e40899f400c5be8"
    }
  },
  {
    "ts": null,
    "headline": "Merck Earnings Beat Analyst Estimates. Why the Stock Is Dropping.",
    "summary": "There is a growing list of challenges to drugs and programs Merck hopes will take up the slack from Keytruda.",
    "url": "https://finnhub.io/api/news?id=2882e025de234379523055e798c0734413f211014488659f7fbc8603b3ac1eda",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753802160,
      "headline": "Merck Earnings Beat Analyst Estimates. Why the Stock Is Dropping.",
      "id": 136119118,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "There is a growing list of challenges to drugs and programs Merck hopes will take up the slack from Keytruda.",
      "url": "https://finnhub.io/api/news?id=2882e025de234379523055e798c0734413f211014488659f7fbc8603b3ac1eda"
    }
  },
  {
    "ts": null,
    "headline": "EXEL Q2 Earnings Top, Sales Miss on Lower Collaboration Revenues",
    "summary": "EXEL beats on Q2 earnings but misses revenues as lower collaboration income offsets strong Cabometyx sales growth.",
    "url": "https://finnhub.io/api/news?id=9d3c1ab032ee2d1506add51603611208e6ddcf09f3da5e7b5718f114301c4256",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753796280,
      "headline": "EXEL Q2 Earnings Top, Sales Miss on Lower Collaboration Revenues",
      "id": 136119442,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "EXEL beats on Q2 earnings but misses revenues as lower collaboration income offsets strong Cabometyx sales growth.",
      "url": "https://finnhub.io/api/news?id=9d3c1ab032ee2d1506add51603611208e6ddcf09f3da5e7b5718f114301c4256"
    }
  },
  {
    "ts": null,
    "headline": "Bain leads $300M investment in startup built on Bristol Myers immune drugs",
    "summary": "Bristol Myers will get a nearly 20% stake in the startup, which will be led by one of its former executives and advance five drugs that no longer fit its plans.",
    "url": "https://finnhub.io/api/news?id=968bf6506b9d40eafb7401b889e448d802141e2f5d02028b05c5e2341cd51412",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753778580,
      "headline": "Bain leads $300M investment in startup built on Bristol Myers immune drugs",
      "id": 136119443,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Bristol Myers will get a nearly 20% stake in the startup, which will be led by one of its former executives and advance five drugs that no longer fit its plans.",
      "url": "https://finnhub.io/api/news?id=968bf6506b9d40eafb7401b889e448d802141e2f5d02028b05c5e2341cd51412"
    }
  }
]